A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment

Clinical Nephrology

Volumn 53, Issue 6, 2000, Pages 479-482

  Kohno, K ^a   Katayama, T ^a   Majima, K ^a   Fujisawa, M ^a   Iida, S ^a   Fukami, K ^a   Ueda, S ^a   Nishida, H ^a   Sata, M ^a   Kato, S ^a   Morimatsu, M ^a   Okuda, S ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hemolytic uremic syndrome; Methylprednisolone; Scleroderma renal crisis; Steroid; Thrombotic thrombocytopenic purpura

Indexed keywords

METHYLPREDNISOLONE;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; GLOMERULUS CAPILLARY; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; MICROANGIOPATHY; SCLERODERMA;

AGED; ANEMIA, HEMOLYTIC; BLOOD PRESSURE; GLUCOCORTICOIDS; HUMANS; KIDNEY; KIDNEY FAILURE; LUNG DISEASES, INTERSTITIAL; MALE; METHYLPREDNISOLONE; SCLERODERMA, SYSTEMIC;

EID: 0034091564     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Brain MC 1970 Microangiopathic hemolytic anemia. Annu Rev Med. 21: 133-142
2. Calvert RJ, Owen TK 1956 True scleroderma kidney. Lancet 271: 19-22
3. Cannon PJ, Hasar M, Cane DB, Casarella WJ, Sommers SC, Leroy EC 1974 The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine 53: 1-46
4. Crutchely DJ, Ryan US, Ryan JW 1985 Glucocorticoid modulation of prostacyclin production in cultured bovine pulmonary endothelial cells. J Pharmacol Exp Ther 233: 650-655
5. Helfrich DJ, Banner B, Steen VD, Medsger TA 1989 Normotensive renal failure in systemic sclerosis. Arthritis Reuma 32: 1128-1134
6. Jhonson SJ, Spiera H 1980 Development of scleroderma renal failure without severe hypertension: five cases (abstract). Arthritis Reuma 23: 698
7. Lewis GD, Campbell WB, Johnson AR 1986 Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology 119: 62-69
8. Linton AL, Gravras H, Gleadle RI, Hutchison HE, Lawson DH, Lever AF, Macadam RF, McNichol GP, Robertson JIS 1969 Microangiopathic haemolytic anemia and the pathogenesis of malignant hypertension. Lancet 1: 1277-1282
9. Lunseth JH, Baker LA, Shifrin A 1951 Chronic scleroderma with acute exacerbation during corticotrophin therapy. Arch Intern Med 88: 783-792
10. Mendelsohn FAO, Lloyd CJ, Kachel C, Fumder JW 1982 Induction by glucocorticoids of angiotensin-converting enzyme production from bovine endothelial cells in culture and rat lung in vivo. J Clin Invest 70: 684-692
11. Moore HC, Sheehan HL 1952 The kidney of scleroderma. Lancet 262: 68-71
12. Salyer WR, Salyer DC, Heptinstall RH 1973 Scleroderma and microangiopathic hemolytic anemia. Ann Intern Med 78: 895-897
13. Schanoff JG, Carideo HL, Stein ID 1951 Cortisone-treated scleroderma. JAMA 145: 1230-1232
14. Steen VD, Medsger TA, Osial TA, Ziegler GL, Shapiro AP, Rodnan GP 1989 Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76: 779-786